טוען...
An analysis of redactions in Canada’s Common Drug Review Clinical Review Reports and how they relate to the patients’ voice
IMPORTANCE: Canada’s Common Drug Review (CDR) evaluates drug data from published and unpublished research, as well as input from patient groups, to recommend provincial coverage. Currently, the CDR process gives manufacturers the opportunity to redact information in the final publicly available repo...
שמור ב:
| הוצא לאור ב: | BMJ Open |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5595205/ https://ncbi.nlm.nih.gov/pubmed/28893743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-015497 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|